Trulicity and Asa drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Trulicity and Asa. Common interactions include swelling face among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people who take Trulicity and Asa have. It is created by eHealthMe based on reports of 73 people who take Trulicity and Asa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
73 people who take Trulicity and Asa together, and have interactions are studied.
What is Trulicity?
Trulicity has active ingredients of dulaglutide. eHealthMe is studying from 46,721 Trulicity users for its effectiveness, alternative drugs and more.
What is Asa?
Asa has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 31,699 Asa users for its effectiveness, alternative drugs and more.
Number of Trulicity and Asa reports submitted per year:
Common Trulicity and Asa drug interactions by gender *:
- Swelling face
- Thirst decreased
- Weight decreased
- Weight increased
- Blood glucose increased
- Hepatic cirrhosis
- Pain in jaw
- Renal failure
- Weight decreased
- Injection site pain
- Blood creatinine increased
- Blood potassium increased
Common Trulicity and Asa drug interactions by age *:
- Diabetic ketoacidosis
- Lactic acidosis
- Renal failure
- Glycosylated haemoglobin increased
- Impaired work ability
- Liver injury
- Pneumonia aspiration
- Reflux gastritis
- Uterine cancer
- Intervertebral disc disorder
- Intervertebral disc protrusion
- Multiple sclerosis
- Multiple sclerosis relapse
- Muscular weakness
- Speech disorder
- Spinal osteoarthritis
Common conditions people have *:
- Type 2 Diabetes: 34 people, 46.58%
- Diabetes: 21 people, 28.77%
- Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 8.22%
- Cushing's Syndrome (obesity, a rounded face, increased fat): 6 people, 8.22%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 5.48%
- High Blood Pressure: 4 people, 5.48%
* Approximation only. Some reports may have incomplete information.
Do you take Trulicity and Asa?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
Alternative drugs to, pros and cons of the 2 drugs:
Common Trulicity and Asa interactions:
- Emesis (process of vomiting): 11 reports
- Nausea and vomiting: 11 reports
- Stomach upset: 11 reports
- Upset stomach: 11 reports
- Vomiting: 11 reports
Browse all drug interactions of Trulicity and Asa:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Trulicity interactions:
Browse all interactions between Trulicity and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Asa interactions:
Browse all interactions between Asa and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on dulaglutide and aspirin (the active ingredients of Trulicity and Asa, respectively), and Trulicity and Asa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.